Applications including "ester"

LT195 - Eighteenth revision Japanese Pharmacopoeia analysis of tranexamic acid -2.00 Condition change within the range specified in the general chromatography- -

LC Technical Note InertSustain AQ-C18
LB161 - Analysis of Clopidogrel sulfate (InertSustain C18) (Under the Condition of the Japanese Pharmacopoeia, Clopidogrel sulfate Tablets) -

LC InertSearch InertSustain C18
LB099 - Analysis of p-Hydroxybenzoic acid n-butyl ester (Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-4
LB094 - Analysis of Pranlukast hydrate (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C8
LB085 - Analysis of Olmesartan medoxomil (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-2
GA191 - Fatty acid methyl ester -

GC InertSearch TC-70
GA348 - Analysis of Paraoxybenzoic acid esters -

GC InertSearch InertCap 5
LB853 - Analysis of p-Hydroxybenzoic acid esters -

LC InertSearch InertSustain C18
LB834 - Analysis of Paraoxybenzoic acid esters -

LC InertSearch InertSustain C18
LB704 - Analysis of Phosphate ester flame retardants (PFRs) -

LC InertSearch InertSustainSwift C18
LB703 - Analysis of Phosphate ester flame retardants (PFRs) -

LC InertSearch InertSustainSwift C18
LB701 - Analysis of chlorpheniramine maleate -

LC InertSearch Inertsil ODS-4
LB659 - Analysis of Tamsulosin hydrochloride (Under the Condition of the Japanese harmacopoeia) -

LC InertSearch Inertsil ODS-HL
LB658 - Analysis of Tamsulosin hydrochloride (Under the Condition of the Japanese harmacopoeia) -

LC InertSearch Inertsil ODS-HL
LB603 - Analysis of Steroids -

LC InertSearch InertSustain Cyano HP
LB593 - Analysis of Steroids -

LC InertSearch InertSustain PFP
LB586 - Analysis of Sterols -

LC InertSearch InertSustain PFP
LT096 - Analysis of Atorvastatin Calcium -

LC Technical Note Inertsil C8-4 Inertsil C8-4 HP
LT094 - Analysis of Preservatives in Foods -Third Report- -

LC Technical Note Inertsil ODS-4
LT076 - Analysis of Preservatives in Foods - Second Report -

LC Technical Note Inertsil ODS-3
LT059 - Analysis of Bio-Diesel Fuel (BDF) by HPLC -

LC Technical Note Inertsil SIL-100A
LT039 - Analysis of Glycyrrhizic Acid in Licorice According to the Japanese Pharmacopoeia -

LC Technical Note
LB532 - Analysis of Sodium Valproate (Under the Condition of the draft for the Japanese Pharmacopoeia, Sodium Valproate Extended-release Tablets B) -

LC InertSearch InertSustain C18
LB531 - Analysis of Sodium Valproate (Under the Condition of the draft for the Japanese Pharmacopoeia, Sodium Valproate Extended-release Tablets A) -

LC InertSearch InertSustain C18
LB517 - Analysis of Glycyrrhizic acid (Under the Condition of the Japanese Standards of Quasi-drug Ingredients, Glycyrrhiza Extracted Powder) -

LC InertSearch InertSustain C18
LB511 - Analysis of Parabens, Estradiol and Progesterone -

LC InertSearch InertSustainSwift C18
LB510 - Analysis of Estradiol and Progesterone (Under the Condition of the draft for the Japanese Standards of Quasi-drug Ingredients, Placental Extract) -

LC InertSearch InertSustainSwift C18
LB503 - Analysis of Warfarin Potassium (Under the Condition of the Japanese Pharmacopoeia 17th edition, (3) Related subatances) -

LC InertSearch InertSustain Cyano
LB489 - Analysis of Azosemide (Under the Condition of the draft for the Japanese Pharmacopoeia, Azosemide Tablets) -

LC InertSearch InertSustain C18
LB461 - Analysis of Phenylephrine Hydrochloride (Under the Condition of USP 39-NF34, Phenylephrine Hydrochloride Injection) -

LC InertSearch InertSustain C18
LB460 - Analysis of Estradiol (Under the Condition of USP 39-NF34) -

LC InertSearch Inertsil ODS-3
LB458 - Analysis of Glyburide (Under the Condition of USP 39-NF34) -

LC InertSearch Inertsil C8
LB426 - Analysis of Diflorason Diacetate(Under the Condition of the Japanese Pharmacopoeia 17th edition) -

LC InertSearch InertSustain C18
LB411 - Analysis of Medroxyprogesterone acetate (Under the Condition of the draft for the Japanese Pharmacopoeia) -

LC InertSearch Inertsil WP300 C18
LB410 - Analysis of Medroxyprogesterone acetate (Under the Condition of the draft for the Japanese Pharmacopoeia) -

LC InertSearch Inertsil WP300 C18
LB404 - Analysis of Preservatives and Sweetener (Inertsil ODS-SP) -

LC InertSearch Inertsil ODS-SP
LB403 - Analysis of Preservatives and Sweetener (Inertsil ODS-4) -

LC InertSearch Inertsil ODS-4
LB402 - Analysis of Preservatives and Sweetener (InertSustain AQ-C18) -

LC InertSearch InertSustain AQ-C18
LB401 - Analysis of Preservatives and Sweetener (InertSustain AQ-C18) -

LC InertSearch InertSustain AQ-C18
LB338 - Analysis of Chlorhexidine gluconate solution -

LC InertSearch Inertsil ODS-4
LB330 - Analysis of Roxithromycin (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB314 - Analysis of Acesulfame potassium (InertSustain C18) (Under the Condition of the JSFA-VIII (Japanese Standards of Food Additives)) -

LC InertSearch InertSustain C18
LB313 - Analysis of Acesulfame potassium (Inertsil ODS-3) (Under the Condition of the JSFA-VIII (Japanese Standards of Food Additives)) -

LC InertSearch Inertsil ODS-3
LB312 - Analysis of Acesulfame potassium (InertSustain C18) (Under the Condition of the JPE (Japanese Pharmaceutical Excipients)) -

LC InertSearch InertSustain C18
LB311 - Analysis of Acesulfame potassium (Inertsil ODS-3) (Under the Condition of the JPE (Japanese Pharmaceutical Excipients)) -

LC InertSearch Inertsil ODS-3
LB291 - Analysis of Ticlopidine hydrochloride (Under the Condition of the Japanese Pharmacopoeia, Ticlopidine hydrochloride Tablets) -

LC InertSearch InertSustain C18
LB284 - Analysis of Silodosin (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB265 - Analysis of Tacrolimus (Under the Condition of the Japanese Pharmacopoeia, Tacrolimus Capsules) -

LC InertSearch Inertsil ODS-2
LB253 - Analysis of Tranilast (Under the Condition of the Japanese Pharmacopoeia, Tranilast Capsules) -

LC InertSearch InertSustain C18
LB242 - Analysis of Preservatives and Sweetener (Inertsil Ph) -

LC InertSearch Inertsil Ph
LB241 - Analysis of Preservatives and Sweetener (InertSustain C18) -

LC InertSearch InertSustain C18
LB240 - Analysis of Preservatives and Sweetener (InertSustain Phenyl) -

LC InertSearch InertSustain Phenyl
LB239 - Analysis of Preservatives and Sweetener (InertSustainSwift C18) -

LC InertSearch InertSustainSwift C18
LB238 - Analysis of Preservatives and Sweetener (InertSustain Phenylhexyl) -

LC InertSearch InertSustain Phenylhexyl
LB237 - Analysis of Preservatives and Sweetener (InertSustain C18) -

LC InertSearch InertSustain C18
LB236 - Analysis of Preservatives and Sweetener (InertSustainSwift C18) -

LC InertSearch InertSustainSwift C18
LB235 - Analysis of Preservatives and Sweetener (InertSustain Phenylhexyl) -

LC InertSearch InertSustain Phenylhexyl
LB204 - Analysis of Metformin hydrochloride (Under the Condition of the Japanese Pharmacopoeia, Metformin hydrochloride Tablets) -

LC InertSearch InertSustain C18
LB193 - Analysis of Pioglitazone hydrochloride (InertSustain C8) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LC InertSearch InertSustain C8
LB192 - Analysis of Pioglitazone hydrochloride (Inertsil C8-3) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LC InertSearch Inertsil C8-3
LB187 - Analysis of Chlorpheniramine maleate (Under the Condition of the Japanese Pharmacopoeia,Chlorpheniramine maleate Tablets) -

LC InertSearch InertSustain C18
LB185 - Analysis of Chlorpheniramine maleate (Under the Condition of the Japanese Pharmacopoeia,Chlorpheniramine maleate Tablets) -

LC InertSearch InertSustain C18
LB181 - Analysis of Glycyrrhiza (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB175 - Analysis of Loxoprofen (Under the Condition of the Japanese Pharmacopoeia, Loxoprofen sodium Tablets) -

LC InertSearch InertSustain C18
LB166 - Analysis of Pravastatin Sodium (Under the Condition of the Japanese Pharmacopoeia,Pravastatin Sodium Tablets) -

LC InertSearch Inertsil WP300 C18
LB162 - Analysis of Clopidogrel sulfate (Inertsil WP300 C18) (Under the Condition of the Japanese Pharmacopoeia, Clopidogrel sulfate Tablets) -

LC InertSearch Inertsil WP300 C18
LB155 - Analysis of Amlodipine besylate (Under the Condition of the Japanese Pharmacopoeia, Candesartan cilexetil and Amlodipine besylate Tablets) -

LC InertSearch Inertsil ODS-4
LB154 - Analysis of Candesartan cilexetil (Under the Condition of the Japanese Pharmacopoeia, Candesartan cilexetil and Amlodipine besylate Tablets) -

LC InertSearch Inertsil ODS-4
LB113 - Analysis of Epalrestat (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB111 - Analysis of Sivelestat sodium hydrate (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB105 - Analysis of Pitavastatin calcium -

LC InertSearch Inertsil ODS-4
LB100 - Analysis of p-Hydroxybenzoic acid n-butyl ester (Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-4
LB098 - Analysis of p-Hydroxybenzoic acid n-propyl ester (Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-4
LB097 - Analysis of p-Hydroxybenzoic acid ethyl ester (Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-4
LB096 - Analysis of p-Hydroxybenzoic acid methyl ester (Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-4
LB087 - Analysis of Naftopidil (Under the Condition of the Japanese Pharmacopoeia, Naftopidil Tablets) -

LC InertSearch InertSustain C18
LB084 - Analysis of Olmesartan medoxomil (Under the Condition of United States Pharmacopeia 35-NF30) -

LC InertSearch InertSustain C18
LB062 - Analysis of Cetiridine hydrochloride (Under the Condition of Japanese Pharmacopoeia, Cetiridine hydrochloride Tablets) -

LC InertSearch Inertsil C8-3
LB058 - Analysis of Amlodipine Besilate (Under the Condition of Japanese Pharmacopoeia, Amlodipine Besilate Tablets) -

LC InertSearch InertSustain C18
LB048 - Analysis of Preservatives (Inertsil ODS-4) -

LC InertSearch Inertsil ODS-4
LB047 - Analysis of Preservatives (Inertsil ODS-4) -

LC InertSearch Inertsil ODS-4
LB046 - Analysis of Preservatives (Inertsil ODS-4) -

LC InertSearch Inertsil ODS-4
LB045 - Analysis of Preservatives (Inertsil ODS-4) -

LC InertSearch Inertsil ODS-4
LB028 - Analysis of Pitavastatin Calcium -

LC InertSearch InertSustain C18
LB025 - Analysis of Atorvastatin Calcium (Under the Condition of Japanese Pharmacopoeia, Atorvastatin Calcium Hydrate) -

LC InertSearch InertSustain C18
LA972 - Analysis of Loxoprofen- InertSustain C18(Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LA971 - Analysis of Loxoprofen- Inertsil ODS-SP(Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-SP
LA955 - Analysis of Parabens (InertSustain C18) -

LC InertSearch InertSustain C18
LA954 - Analysis of Parabens (Inertsil ODS-4) -

LC InertSearch Inertsil ODS-4
LA953 - Analysis of Parabens (Inertsil ODS-3) -

LC InertSearch Inertsil ODS-3
LA952 - Analysis of Parabens (InertSustain C18) -

LC InertSearch InertSustain C18
LA951 - Analysis of Parabens (Inertsil ODS-4) -

LC InertSearch Inertsil ODS-4
LA950 - Analysis of Parabens (Inertsil ODS-3) -

LC InertSearch Inertsil ODS-3
LA947 - Analysis of Parabens (InertSustain C18) -

LC InertSearch InertSustain C18
LA946 - Analysis of Parabens (Inertsil ODS-4) -

LC InertSearch Inertsil ODS-4
LA928 - Analysis of Phorbol esters -

LC InertSearch Inertsil ODS-4
LA905 - Analysis of Glycyrrhiza Standard (InertSustain C18) -

LC InertSearch InertSustain C18
LA899 - Analysis of Rifampicin(Under the Condition of Japanese Pharmacopoeia 16) -

LC InertSearch Inertsil C8-4
LA891 - Analysis of Phytosterol (InertSustain C18) -

LC InertSearch InertSustain C18 HP
LA868 - Analysis of Phytosterol(MonoClad C18-HS) -

LC InertSearch MonoClad C18-HS
LA867 - Analysis of Phytosterol(Inertsil ODS-SP) -

LC InertSearch Inertsil ODS-SP
LA866 - Analysis of Phytosterol(Inertsil ODS-4) -

LC InertSearch Inertsil ODS-4
LA865 - Analysis of Phytosterol(Inertsil ODS-3) -

LC InertSearch Inertsil ODS-3
LA847 - Analysis of Indomethacin (Inertsil ODS-SP) -

LC InertSearch Inertsil ODS-SP
LA846 - Analysis of Indomethacin (Inertsil ODS-4) -

LC InertSearch Inertsil ODS-4
LA845 - Analysis of Indomethacin (Inertsil ODS-3) -

LC InertSearch Inertsil ODS-3
LA823 - Analysis of Hormone -

LC InertSearch MonoClad C18-HS
LA821 - Analysis of Aromatic carboxylic acid -

LC InertSearch MonoClad C18-HS
LA818 - Analysis of Preservatives -

LC InertSearch MonoClad C18-HS
LA685 - Analysis of Preservatives -

LC InertSearch Inertsil ODS-4
LA626 - Analysis of para-hydroxybenzoates -

LC InertSearch Inertsil ODS-3
LA550 - Analysis of Glycyrrhiza Standard (Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-SP
LA545 - Analysis of Glycyrrhizin -

LC InertSearch Inertsil ODS-3
LA354 - Analysis of Amitriptyline -

LC InertSearch Inertsil C8-3
LA353 - Analysis of Amitriptyline -

LC InertSearch Inertsil ODS-3V
LA331 - Analysis of Phthalic acid dialkylester -

LC InertSearch Inertsil C8-3
LA253 - Analysis of Steroid Hormones -

LC InertSearch Inertsil CN-3
LA252 - Analysis of Steroid Hormones -

LC InertSearch Inertsil SIL-100A
LA251 - Analysis of Steroid Hormones -

LC InertSearch Inertsil Diol
LA243 - Analysis of Adrenocortical hormones -

LC InertSearch Inertsil CN-3
LA242 - Analysis of Adrenocortical hormones -

LC InertSearch Inertsil CN-3
LA212 - Analysis of Cortisone acetate -

LC InertSearch Inertsil ODS-3
LA211 - Estradiol benzoate -

LC InertSearch Inertsil ODS-3
LA205 - Analysis of Glycyrrhizin -

LC InertSearch Inertsil ODS-P
LA199 - Indometacin -

LC InertSearch Inertsil ODS-3
LA197 - Analysis of Glycyrrhizin -

LC InertSearch Inertsil Ph-3
LA196 - Analysis of Glycyrrhizin -

LC InertSearch Inertsil ODS-3V
LA195 - Analysis of Phenothiazines -

LC InertSearch Inertsil ODS-3V
LA188 - Analysis of Estriol -

LC InertSearch Inertsil ODS-3V
LA186 - Analysis of Dinoprost -

LC InertSearch Inertsil ODS-3V
LA185 - Analysis of Deferoxamine mesilate -

LC InertSearch Inertsil ODS-3V
LA184 - Analysis of Alprostadil -

LC InertSearch Inertsil ODS-3V
LA177 - Analysis of Baclofen -

LC InertSearch Inertsil ODS-3V
LA176 - Analysis of Betamethasone -

LC InertSearch Inertsil ODS-3V
LA175 - Analysis of Betamethasone sodium phosphate -

LC InertSearch Inertsil ODS-3V
LA173 - Analysis of Bisacodyl -

LC InertSearch Inertsil ODS-3V
LA172 - Analysis of Diclofenac sodium -

LC InertSearch Inertsil ODS-3V
LA171 - Analysis of Fluocinolone acetonide(column select) -

LC InertSearch Inertsil ODS-3V
LA170 - Analysis of Fluocinolone acetonide -

LC InertSearch Inertsil ODS-3V
LA166 - Analysis of Prednisolone succinate -

LC InertSearch Inertsil ODS-3V
LA164 - Analysis of Reserpine -

LC InertSearch Inertsil ODS-3V
LA141 - Recycle preparative purification of Steroids -

LC InertSearch Inertsil PREP-ODS
LA105 - Analysis of Parabens -

LC InertSearch Inertsil Diol
LA104 - Analysis of Parabens -

LC InertSearch Inertsil SIL-100A
LA103 - Analysis of Parabens -

LC InertSearch Inertsil Diol
LA089 - Analysis of Preservatives -

LC InertSearch Inertsil ODS-3V
LA088 - Analysis of Preservatives -

LC InertSearch Inertsil Ph-3
LA082 - Analysis of Food additives -

LC InertSearch Inertsil ODS-3V
LA081 - Analysis of Food additives -

LC InertSearch Inertsil ODS-3V
LA056 - Food additives -

LC InertSearch Inertsil Ph
LA028 - Drug -

LC InertSearch Inertsil ODS-3V
GT119 - Direct Heating Analysis of Commercial Food Wraps - Using HandyTD Portable Thermal Desorber -

GC Technical Note InertCap 5MS/Sil
GT033 - Easy Enrichment of the VOC in a New Car with MonoTrap -

GC Technical Note InertCap Pure-WAX
GA293 - Fatty acid methyl ester -

GC InertSearch InertCap Pure-WAX
GA292 - Hydoroxy fatty acid methyl esters & Non-hydroxy fatty acid methyl esters in Galactocerebroside from bovine brain -

GC InertSearch InertCap 5MS
GA278 - Analysis of Sulfonic acid ester -

GC InertSearch InertCap 5MS
GA192 - Fatty acid methyl ester -

GC InertSearch TC-2560
GA189 - Phthalic acid esters -

GC InertSearch InertCap 5MS
GA180 - Glycerol and Mono-, Di-, Triglyceride by EN14105 -

GC InertSearch InertCap 5
GA179 - Phthalic acid esters by the GB/T 21911-2008 -

GC InertSearch InertCap 5MS
GA178 - Phthalic acid esters by the GB/T 21911-2008 -

GC InertSearch InertCap 5MS/Sil
GA177 - Phthalic acid esters -

GC InertSearch InertCap 5MS/Sil
GA176 - Phthalic acid esters -

GC InertSearch InertCap 5MS
GA170 - Methyl methacrylate -

GC InertSearch InertCap 1
GA152 - Phthalic acid esters -

GC InertSearch InertCap 5MS/Sil
GA146 - Phthalic acid esters -

GC InertSearch InertCap 1MS
GA117 - Lactate ester -

GC InertSearch InertCap 5
GA116 - Lactate ester -

GC InertSearch InertCap Pure-WAX
GA080 - Fatty acid methyl ester -

GC InertSearch InertCap Pure-WAX
GA073 - Fatty acid methyl ester -

GC InertSearch InertCap Pure-WAX
GA072 - Fatty acid methyl ester -

GC InertSearch InertCap Pure-WAX
GA052 - Phthalate ester -

GC InertSearch InertCap 5MS/Sil
GA051 - Phthalate ester -

GC InertSearch InertCap 1
GA050 - Fatty acid methyl ester (FAME) -

GC InertSearch InertCap WAX
GA049 - Halogenoacetic acid -

GC InertSearch InertCap 5MS/Sil
GA048 - Halogenoacetic acid -

GC InertSearch InertCap 1
GA032 - Sterols -

GC InertSearch InertCap 1
GA020 - Phthalate esters -

GC InertSearch InertCap 1
GA016 - Cholesterols -

GC InertSearch InertCap 1

Applications including "ester"

LT195 - Eighteenth revision Japanese Pharmacopoeia analysis of tranexamic acid -2.00 Condition change within the range specified in the general chromatography- -

LB161 - Analysis of Clopidogrel sulfate (InertSustain C18) (Under the Condition of the Japanese Pharmacopoeia, Clopidogrel sulfate Tablets) -

LB099 - Analysis of p-Hydroxybenzoic acid n-butyl ester (Under the Condition of Japanese Pharmacopoeia) -

LB094 - Analysis of Pranlukast hydrate (Under the Condition of the Japanese Pharmacopoeia) -

LB085 - Analysis of Olmesartan medoxomil (Under the Condition of the Japanese Pharmacopoeia) -

GA191 - Fatty acid methyl ester -

GA348 - Analysis of Paraoxybenzoic acid esters -

LB853 - Analysis of p-Hydroxybenzoic acid esters -

LB834 - Analysis of Paraoxybenzoic acid esters -

LB704 - Analysis of Phosphate ester flame retardants (PFRs) -

LB703 - Analysis of Phosphate ester flame retardants (PFRs) -

LB701 - Analysis of chlorpheniramine maleate -

LB659 - Analysis of Tamsulosin hydrochloride (Under the Condition of the Japanese harmacopoeia) -

LB658 - Analysis of Tamsulosin hydrochloride (Under the Condition of the Japanese harmacopoeia) -

LB603 - Analysis of Steroids -

LB593 - Analysis of Steroids -

LB586 - Analysis of Sterols -

LT096 - Analysis of Atorvastatin Calcium -

LT094 - Analysis of Preservatives in Foods -Third Report- -

LT076 - Analysis of Preservatives in Foods - Second Report -

LT059 - Analysis of Bio-Diesel Fuel (BDF) by HPLC -

LT039 - Analysis of Glycyrrhizic Acid in Licorice According to the Japanese Pharmacopoeia -

LB532 - Analysis of Sodium Valproate (Under the Condition of the draft for the Japanese Pharmacopoeia, Sodium Valproate Extended-release Tablets B) -

LB531 - Analysis of Sodium Valproate (Under the Condition of the draft for the Japanese Pharmacopoeia, Sodium Valproate Extended-release Tablets A) -

LB517 - Analysis of Glycyrrhizic acid (Under the Condition of the Japanese Standards of Quasi-drug Ingredients, Glycyrrhiza Extracted Powder) -

LB511 - Analysis of Parabens, Estradiol and Progesterone -

LB510 - Analysis of Estradiol and Progesterone (Under the Condition of the draft for the Japanese Standards of Quasi-drug Ingredients, Placental Extract) -

LB503 - Analysis of Warfarin Potassium (Under the Condition of the Japanese Pharmacopoeia 17th edition, (3) Related subatances) -

LB489 - Analysis of Azosemide (Under the Condition of the draft for the Japanese Pharmacopoeia, Azosemide Tablets) -

LB461 - Analysis of Phenylephrine Hydrochloride (Under the Condition of USP 39-NF34, Phenylephrine Hydrochloride Injection) -

LB460 - Analysis of Estradiol (Under the Condition of USP 39-NF34) -

LB458 - Analysis of Glyburide (Under the Condition of USP 39-NF34) -

LB426 - Analysis of Diflorason Diacetate(Under the Condition of the Japanese Pharmacopoeia 17th edition) -

LB411 - Analysis of Medroxyprogesterone acetate (Under the Condition of the draft for the Japanese Pharmacopoeia) -

LB410 - Analysis of Medroxyprogesterone acetate (Under the Condition of the draft for the Japanese Pharmacopoeia) -

LB404 - Analysis of Preservatives and Sweetener (Inertsil ODS-SP) -

LB403 - Analysis of Preservatives and Sweetener (Inertsil ODS-4) -

LB402 - Analysis of Preservatives and Sweetener (InertSustain AQ-C18) -

LB401 - Analysis of Preservatives and Sweetener (InertSustain AQ-C18) -

LB338 - Analysis of Chlorhexidine gluconate solution -

LB330 - Analysis of Roxithromycin (Under the Condition of the Japanese Pharmacopoeia) -

LB314 - Analysis of Acesulfame potassium (InertSustain C18) (Under the Condition of the JSFA-VIII (Japanese Standards of Food Additives)) -

LB313 - Analysis of Acesulfame potassium (Inertsil ODS-3) (Under the Condition of the JSFA-VIII (Japanese Standards of Food Additives)) -

LB312 - Analysis of Acesulfame potassium (InertSustain C18) (Under the Condition of the JPE (Japanese Pharmaceutical Excipients)) -

LB311 - Analysis of Acesulfame potassium (Inertsil ODS-3) (Under the Condition of the JPE (Japanese Pharmaceutical Excipients)) -

LB291 - Analysis of Ticlopidine hydrochloride (Under the Condition of the Japanese Pharmacopoeia, Ticlopidine hydrochloride Tablets) -

LB284 - Analysis of Silodosin (Under the Condition of the Japanese Pharmacopoeia) -

LB265 - Analysis of Tacrolimus (Under the Condition of the Japanese Pharmacopoeia, Tacrolimus Capsules) -

LB253 - Analysis of Tranilast (Under the Condition of the Japanese Pharmacopoeia, Tranilast Capsules) -

LB242 - Analysis of Preservatives and Sweetener (Inertsil Ph) -

LB241 - Analysis of Preservatives and Sweetener (InertSustain C18) -

LB240 - Analysis of Preservatives and Sweetener (InertSustain Phenyl) -

LB239 - Analysis of Preservatives and Sweetener (InertSustainSwift C18) -

LB238 - Analysis of Preservatives and Sweetener (InertSustain Phenylhexyl) -

LB237 - Analysis of Preservatives and Sweetener (InertSustain C18) -

LB236 - Analysis of Preservatives and Sweetener (InertSustainSwift C18) -

LB235 - Analysis of Preservatives and Sweetener (InertSustain Phenylhexyl) -

LB204 - Analysis of Metformin hydrochloride (Under the Condition of the Japanese Pharmacopoeia, Metformin hydrochloride Tablets) -

LB193 - Analysis of Pioglitazone hydrochloride (InertSustain C8) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LB192 - Analysis of Pioglitazone hydrochloride (Inertsil C8-3) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LB187 - Analysis of Chlorpheniramine maleate (Under the Condition of the Japanese Pharmacopoeia,Chlorpheniramine maleate Tablets) -

LB185 - Analysis of Chlorpheniramine maleate (Under the Condition of the Japanese Pharmacopoeia,Chlorpheniramine maleate Tablets) -

LB181 - Analysis of Glycyrrhiza (Under the Condition of the Japanese Pharmacopoeia) -

LB175 - Analysis of Loxoprofen (Under the Condition of the Japanese Pharmacopoeia, Loxoprofen sodium Tablets) -

LB166 - Analysis of Pravastatin Sodium (Under the Condition of the Japanese Pharmacopoeia,Pravastatin Sodium Tablets) -

LB162 - Analysis of Clopidogrel sulfate (Inertsil WP300 C18) (Under the Condition of the Japanese Pharmacopoeia, Clopidogrel sulfate Tablets) -

LB155 - Analysis of Amlodipine besylate (Under the Condition of the Japanese Pharmacopoeia, Candesartan cilexetil and Amlodipine besylate Tablets) -

LB154 - Analysis of Candesartan cilexetil (Under the Condition of the Japanese Pharmacopoeia, Candesartan cilexetil and Amlodipine besylate Tablets) -

LB113 - Analysis of Epalrestat (Under the Condition of the Japanese Pharmacopoeia) -

LB111 - Analysis of Sivelestat sodium hydrate (Under the Condition of the Japanese Pharmacopoeia) -

LB105 - Analysis of Pitavastatin calcium -

LB100 - Analysis of p-Hydroxybenzoic acid n-butyl ester (Under the Condition of Japanese Pharmacopoeia) -

LB098 - Analysis of p-Hydroxybenzoic acid n-propyl ester (Under the Condition of Japanese Pharmacopoeia) -

LB097 - Analysis of p-Hydroxybenzoic acid ethyl ester (Under the Condition of Japanese Pharmacopoeia) -

LB096 - Analysis of p-Hydroxybenzoic acid methyl ester (Under the Condition of Japanese Pharmacopoeia) -

LB087 - Analysis of Naftopidil (Under the Condition of the Japanese Pharmacopoeia, Naftopidil Tablets) -

LB084 - Analysis of Olmesartan medoxomil (Under the Condition of United States Pharmacopeia 35-NF30) -

LB062 - Analysis of Cetiridine hydrochloride (Under the Condition of Japanese Pharmacopoeia, Cetiridine hydrochloride Tablets) -

LB058 - Analysis of Amlodipine Besilate (Under the Condition of Japanese Pharmacopoeia, Amlodipine Besilate Tablets) -